MOXEN Meloxicam 15mg Tablet 20's
RXDRUG-DRP-370-01
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Indications/Uses
Meloxicam is used in the management of rheumatoid arthritis, for the short-term symptomatic treatment of acute exacerbations of osteoarthritis and for the symptomatic treatment of ankylosing spondylitis.
Dosage/Direction for Use
In the treatment of rheumatoid arthritis and ankylosing spondylitis, meloxicam is given by mouth in a usual dose of 15 mg daily as single dose.
Those with an increased risk of adverse reactions should be started on 7.5 mg daily. A dose of 7.5 mg daily is recommended for a long-term treatment in the elderly. In the treatment of acute exacerbations of osteoarthritis the usual daily dose of meloxicam by mouth is 7.5 mg increased if necessary to a maximum of 15 mg daily given as a single dose.
The recommended maximum daily dose in dialysis patients is 7.5 mg.
Those with an increased risk of adverse reactions should be started on 7.5 mg daily. A dose of 7.5 mg daily is recommended for a long-term treatment in the elderly. In the treatment of acute exacerbations of osteoarthritis the usual daily dose of meloxicam by mouth is 7.5 mg increased if necessary to a maximum of 15 mg daily given as a single dose.
The recommended maximum daily dose in dialysis patients is 7.5 mg.
Administration
May be taken with or without food: May be taken w/ meals if GI discomfort occurs.
Contraindications
Absolute Contraindications: Not to be given to those patients who have history of stroke, cerebrovascular accident (CVA), heart attack, myocardial infarction (MI), coronary artery bypass graft (CABG), uncontrolled hypertension, congestive heart failure (CHF) NYHA IV.
Patients with history of hypersensitivity to ASA or to any other NSAID's. Patients with previous or active peptic ulceration.
Patients with history of hypersensitivity to ASA or to any other NSAID's. Patients with previous or active peptic ulceration.
Special Precautions
Use with caution in patients with cardiac, liver and renal disease. Dose adjustment like using the lowest effective dose and monitoring of renal and liver functions should be instituted.
Adverse Reactions
The most common adverse effects occurring during therapy with NSAIDs are generally GI disturbances, eg GI discomfort, nausea and diarrhea. These are usually mild and reversible but in some patients peptic ulceration and severe GI bleeding may occur.
CNS related side effects include headache, vertigo, dizziness, nervousness, tinnitus, depression, drowsiness and insomnia. Hypersensitivity reactions may occur occasionally and include fever, angioedema, bronchospasm and rashes. Hepatotoxicity and aseptic meningitis, which occur lately, may also be hypersensitivity reactions. Some patients may experience visual disturbances.
Hematological adverse effects of NSAIDs include anemias, thrombocytopenia, neutropenia, eosinophilia and agranulocytosis.
CNS related side effects include headache, vertigo, dizziness, nervousness, tinnitus, depression, drowsiness and insomnia. Hypersensitivity reactions may occur occasionally and include fever, angioedema, bronchospasm and rashes. Hepatotoxicity and aseptic meningitis, which occur lately, may also be hypersensitivity reactions. Some patients may experience visual disturbances.
Hematological adverse effects of NSAIDs include anemias, thrombocytopenia, neutropenia, eosinophilia and agranulocytosis.
Drug Interactions
There may be an increased risk of bleeding during concomitant use of meloxicam and oxpentifylline.
Storage
Store at temperatures not exceeding 30°C.
Action
Pharmacology: Pharmacokinetics: Meloxicam is well absorbed following oral administration. It is 99% bound to plasma proteins. It has a plasma elimination t½ of approximately 20 hrs. It is extensively metabolized mainly by oxidation and excreted in similar amounts in the urine and in the feces, <3% of a dose is excreted unchanged.
The volume of distribution is increased in severe renal failure.
The volume of distribution is increased in severe renal failure.
MedsGo Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Features
Brand
Moxen
Full Details
Dosage Strength
15 mg
Drug Ingredients
- Meloxicam
Drug Packaging
Tablet 20's
Generic Name
Meloxicam
Dosage Form
Tablet
Registration Number
DRP-370-01
Drug Classification
Prescription Drug (RX)
Please sign in so that we can notify you about a reply